Open AccessSurvival analysis of endometrial cancer patients with cervical stromal involvement
Author(s) -
Jonathan Frandsen,
William T. Sause,
Mark K. Dodson,
Andrew P. Soisson,
Tom Belnap,
David K. Gaffney
Publication year - 2014
Publication title -
journal of gynecologic oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.358
H-Index - 37
eISSN - 2005-0399
pISSN - 2005-0380
DOI - 10.3802/jgo.2014.25.2.105
Subject(s) - medicine , endometrial cancer , cervical cancer , stage (stratigraphy) , radiation therapy , retrospective cohort study , oncology , adjuvant therapy , cancer , gynecology , paleontology , biology
Stage II endometrial cancer is relatively uncommon. There is no consensus for appropriate adjuvant therapy in endometrial cancer patients with cervical stromal involvement (International Federation of Gynecology and Obstetrics [FIGO] stage II). This study investigates how adjuvant treatments and tumor characteristics influence overall survival (OS) and disease-free survival (DFS) in stage II patients in order to establish better treatment guidelines.